» Articles » PMID: 31002990

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations

Abstract

The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic services. Although this is may be a limiting factor, these countries should prioritize development of the needed expertise to offer state-of-the-art treatments, including transplantation, by providing financial, technological, legal, ethical, and other needed support. This would prove beneficial in providing successful programs customized to the needs of their population and potentially provide long-term cost savings by circumventing the need for their citizens to seek care abroad. The costs of establishing an HSCT program and the costs of the HSCT procedure itself can be substantial barriers in developing countries. In addition, socioeconomic factors intrinsic to specific countries can influence access to HSCT, patient eligibility for HSCT, and timely utilization of HSCT center capabilities. This report describes recommendations from the Worldwide Network for Blood and Marrow Transplantation for establishing HSCT programs, with a specific focus on developing countries, and identifies challenges and opportunities for providing this specialized procedure in resource-constrained settings.

Citing Articles

Brave new world: expanding home care in stem cell transplantation and advanced therapies with new technologies.

Romon I, Gonzalez-Barrera S, Coello de Portugal C, Ocio E, Sampedro I Front Immunol. 2024; 15:1366962.

PMID: 38736880 PMC: 11082320. DOI: 10.3389/fimmu.2024.1366962.


Post-Transplant Complications in Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT)-A Comparative Analysis of Home Care versus Hospitalized Patients.

Garces-Carrasco A, Santacatalina-Roig E, Carretero-Marquez C, Chover-Sierra E, Martinez-Sabater A, Balaguer-Lopez E Medicina (Kaunas). 2024; 60(1).

PMID: 38256305 PMC: 10821161. DOI: 10.3390/medicina60010044.


Common mental disorders in hematopoietic stem cell transplant patients: a scoping review.

Almeida A, Azevedo V, Alves T, Santos V, Silva G, Azevedo I Rev Bras Enferm. 2023; 77(1):e20220581.

PMID: 38088687 PMC: 10704667. DOI: 10.1590/0034-7167-2022-0581.


Hematopoietic cell transplantation landscape in India.

Nair V, Yanamandra U, Nazneen P Med J Armed Forces India. 2023; 79(6):621-630.

PMID: 37981919 PMC: 10654369. DOI: 10.1016/j.mjafi.2023.09.002.


Developing an Allogeneic Hematopoietic Progenitor Cell Transplant Service in a Resource-Limited Country: Challenges and Outcomes.

Mahar U, Ahsan B, Ahmad U, Bokhari S Cureus. 2023; 15(9):e44818.

PMID: 37809142 PMC: 10559081. DOI: 10.7759/cureus.44818.